PDCD1 and neoplasm: Although the average tumor weights from ACA + anti-PD-1 did not significantly differ from ACA NT or CON + anti-PD-1, treatment with ACA + anti-PD-1 resulted in 41% of mice achieving tumor weights within 0.2 g of an average tumor-free kidney (as designated by the dotted line) (Figure 5B,C).